February 5, 2015 by Brian Johnson
Smith & Nephew CEO Olivier Bohoun calls the ‘no-frills’ Syncera program, which replaces sales reps with an automated system, a growth driver but refuses to set expectations.
Smith & Nephew (FTSE:SN, NYSE:SNN) CEO Olivier Bohoun is bullish on the prospects for the company’s Syncera pilot program, which replaces sales reps with an automated system, to become a growth driver in the years to come.
How much of a driver Bohoun thinks the “no-frills” approach to selling orthopedic reconstruction equipment will be, however, he’s keeping to himself for now.
During a conference call with analysts today discussing Smith & Nephew’s 4th-quarter earnings, Bohoun repeatedly touted the Syncera pilot as “disruptive” to the orthopedics business model, but said the company isn’t releasing any numbers on it until the middle of this year.